Clinical Trial Update: Biomarkers of Liver Fibrosis

View source ↗

Summary

A clinical trial investigating biomarkers of liver fibrosis in hepatitis C has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Hepatitis C | Status: TERMINATED